Label reference · Immune & inflammatory
Actemra (Tocilizumab) Injection, Solution, Concentrate Actemra (Tocilizumab) Injection, Solution Actemra Actpen (Tocilizumab) Injection, Solution — label reference
DailyMed · Retrieved 2026-10-13
Actemra; Actemra; Actemra Actpen is listed in DailyMed as injection, solution, concentrate; injection, solution. Active ingredient: tocilizumab. This reference records product facts and version 53; the original prescribing information and PDF are linked.
Reference details
- Brand / product name
- ACTEMRA; Actemra; Actemra ACTPen
- Generic product name
- tocilizumab
- Active ingredient
- TOCILIZUMAB
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE; INJECTION, SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- SPL author / labeler
- Genentech, Inc.
- SPL version
- 53
- Published on DailyMed
- 2025-12-19
- SPL effective date
- 2025-12-16
- SPL set ID
- 2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13
Product identity
Product name: ACTEMRA; Actemra; Actemra ACTPen
Generic name: tocilizumab
Active ingredients: TOCILIZUMAB
Dosage form: INJECTION, SOLUTION, CONCENTRATE; INJECTION, SOLUTION
Route: INTRAVENOUS; SUBCUTANEOUS
Label version
DailyMed published this record on 2025-12-19. SPL version: 53. Set ID: 2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13. The SPL effective date is 2025-12-16.
Original prescribing information
Open the original DailyMed label or PDF below for indications, contraindications, dosing instructions, interactions and warnings. This page contains factual product metadata, not the full prescribing information.
Sources and reuse
- Original DailyMed label
- Original label PDF
- Official SPL XML
- Factual label metadata; original label linked
Bibliographic or product metadata. Read the original source for the complete document.
Source date: 2025-12-19. Retrieved: 2026-10-13. Text has been organized for reading; this import has not been independently reviewed by a clinician. It is not individualized medical advice.